Cloud-clone
SKU:SEF757Hu
ELISA Kit for Peroxiredoxin 2 (PRDX2)
ELISA Kit for Peroxiredoxin 2 (PRDX2)
Couldn't load pickup availability
Enzyme-linked immunosorbent assay for Antigen Detection.
Product No.
SEF757Hu
Organism Species
Homo sapiens (Human).
Sample Type
serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids
Test Method
Double-antibody Sandwich
Assay Length
3h
Detection Range
7.8-500ng/mL
Sensitivity
The minimum detectable dose of this kit is typically less than 3.1ng/mL.
UOM
48T 96T 96T*5 96T*10 96T*100
Specificity
This assay has high sensitivity and excellent specificity for detection of Peroxiredoxin 2 (PRDX2).
No significant cross-reactivity or interference between Peroxiredoxin 2 (PRDX2) and analogues was observed.
Recovery
Matrices listed below were spiked with certain level of recombinant Peroxiredoxin 2 (PRDX2) and the recovery rates were calculated by comparing the measured value to the expected amount of Peroxiredoxin 2 (PRDX2) in samples.
| Matrix | Recovery range (%) | Average(%) |
| serum(n=5) | 78-101 | 88 |
| EDTA plasma(n=5) | 88-104 | 99 |
| heparin plasma(n=5) | 79-90 | 78 |
Precision
Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Peroxiredoxin 2 (PRDX2) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Peroxiredoxin 2 (PRDX2) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%
Linearity
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Peroxiredoxin 2 (PRDX2) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
| Sample | 1:2 | 1:4 | 1:8 | 1:16 |
| serum(n=5) | 89-96% | 96-105% | 83-104% | 85-94% |
| EDTA plasma(n=5) | 83-96% | 93-101% | 93-105% | 95-102% |
| heparin plasma(n=5) | 98-105% | 78-90% | 85-94% | 89-98% |
Stability
The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.
Reagents and materials provided
| Reagents | Quantity | Reagents | Quantity |
| Pre-coated, ready to use 96-well strip plate | 1 | Plate sealer for 96 wells | 4 |
| Standard | 2 | Standard Diluent | 1×20mL |
| Detection Reagent A | 1×120µL | Assay Diluent A | 1×12mL |
| Detection Reagent B | 1×120µL | Assay Diluent B | 1×12mL |
| TMB Substrate | 1×9mL | Stop Solution | 1×6mL |
| Wash Buffer (30 × concentrate) | 1×20mL | Instruction manual | 1 |
Assay procedure summary
1. Prepare all reagents, samples and standards;
2. Add 100µL standard or sample to each well. Incubate 1 hours at 37°C;
3. Aspirate and add 100µL prepared Detection Reagent A. Incubate 1 hour at 37°C;
4. Aspirate and wash 3 times;
5. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
6. Aspirate and wash 5 times;
7. Add 90µL Substrate Solution. Incubate 10-20 minutes at 37°C;
8. Add 50µL Stop Solution. Read at 450nm immediately.
| Magazine | Citations |
| Free Radical Research | Thalassemia major patients using iron chelators showed a reduced plasma thioredoxin level and reduced thioredoxin reductase activity, despite elevated oxidative stress Pubmed:25564095 |
| PLoS One | Differences in Proinflammatory Property of Six Subtypes of Peroxiredoxins and Anti-Inflammatory Effect of Ligustilide in Macrophages pubmed:27716839 |
| Experiental And Therapeutic Medicine | Plasma proteins as potential targets of abnormal Savda syndrome in asthma patients treated with unique Uighur prescription pubmed:28672924 |
| Oncotarget | Neuroprotective effect of a novel gastrodin derivative against ischemic brain injury: involvement of peroxiredoxin and TLR4 signaling inhibition pubmed:29207618 |
| European Journal of Applied Physiology | Prolonged forearm ischemia attenuates endothelium-dependent vasodilatation and plasma nitric oxide metabolites in overweight middle-aged men Pubmed:29785503 |
| Journal of Applied Physiology | Montmorency cherry supplementation attenuates vascular dysfunction induced by prolonged forearm occlusion in overweight middle-aged men Pubmed: 30496705 |
| ACS Omega | SOD1 is a Possible Predictor of COVID-19 Progression as Revealed by Plasma Proteomics 34250342 |
| Catalog No. | Related products for research use of Homo sapiens (Human) Organism species | Applications (RESEARCH USE ONLY!) |
| RPF757Hu02 | Recombinant Peroxiredoxin 2 (PRDX2) | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPF757Hu03 | Recombinant Peroxiredoxin 2 (PRDX2) | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPF757Hu01 | Recombinant Peroxiredoxin 2 (PRDX2) | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAF757Hu01 | Polyclonal Antibody to Peroxiredoxin 2 (PRDX2) | WB; IHC; ICC; IP. |
| PAF757Hu03 | Polyclonal Antibody to Peroxiredoxin 2 (PRDX2) | WB; IHC; ICC; IP. |
| PAF757Hu02 | Polyclonal Antibody to Peroxiredoxin 2 (PRDX2) | WB; IHC; ICC; IP. |
| MAF757Hu23 | Monoclonal Antibody to Peroxiredoxin 2 (PRDX2) | WB; IHC; ICC; IP. |
| MAF757Hu21 | Monoclonal Antibody to Peroxiredoxin 2 (PRDX2) | WB |
| WEF757Hu | Wide-range ELISA Kit for Peroxiredoxin 2 (PRDX2) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| SEF757Hu | ELISA Kit for Peroxiredoxin 2 (PRDX2) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMF757Hu | Magnetic Luminex Assay Kit for Peroxiredoxin 2 (PRDX2) ,etc. | Magnetic Luminex Assay for Antigen Detection. |
Share
